Ann: First Commercial Sale of APAS Independence, page-73

it is surprising to some degree that anyone would be selling at a lower price when the outlook is for another 4 sales before end 2018.

but as pointed out previously - part of the equation comes down to trust. do shareholders trust management will deliver? (past performance Is a good IndIcator). And there are those of course who sell based on various financial reasons to release capital.

I am in this for the next 5months at least - I think there is a promising ride ahead. the Lab in Europe must have also arrived at the conclusion that it is a no brainer from an efficiency perspective to buy several of the APAS. I expect part of the challenge is getting through the procurement hurdles with hospitals. the process of spending $300k plus can push hospitals into tenders, and demonstrating there is no alternative product in market wIty busIness cases... yada yada yada. and 6months later you finally get a sale ( the first sale a point in case- the sale was imminent for what seemed an eternity!).

this one requires patience.